Omalizumab

ATC R03DX05 · 12 markets · 110 records

Omalizumab 12 markets · 110 records Forms

Strength / form / release	US	GB	CA	AU	SG	CN	ES	MX	TW	HK	EU	FR
150 mg injection	Manufacturer: Novartis Pharma Stein AG ×4 OMLYCLO Xolair PFS	Xolair 150mg powder and solvent for solution for injection vials	not recorded	MOVABEY omalizumab (rch) 75 mg solution for injection pre-filled pen OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection in a pre-filled syringe with needle guard OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection pre-filled pen +3 XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe XOLAIR omalizumab (rch) 75mg powder for injection vial with diluent ampoule	not recorded	恩益坦奥马珠单抗茁乐奥马珠单抗	OMLYCLO PRECARGADA Xolair	not recorded	Omlyclo soluiton for Xolair 150 mg powder and solvent for solution for Xolair 150mg/mL Solution for +3 休敏樂注射液劑150毫克/毫升喜瑞樂凍晶注射劑150毫克喜瑞樂注射液劑150毫克/毫升	not recorded	not recorded	not recorded
75 mg/0.5 mL injection	Manufacturer: Novartis Pharma Stein AG ×4 OMLYCLO Xolair PFS	Omlyclo 75mg/0.5ml solution for injection pre-filled pens Omlyclo 75mg/0.5ml solution for injection pre-filled syringes Xolair 150mg/1ml solution for injection pre-filled pens +1 Xolair 75mg/0.5ml solution for injection pre-filled syringes	not recorded	OMLYCLO Xolair	OMLYCLO® SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150 MG/1ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	OMLYCLO 150 mg, solution injectable en seringue préremplie OMLYCLO 150 mg, solution injectable en stylo prérempli XOLAIR 150 mg, solution injectable en seringue préremplie +1 XOLAIR 150 mg, solution injectable en stylo prérempli
150 mg/1 mL injection	not recorded	Omlyclo 75mg/0.5ml solution for injection pre-filled pens Omlyclo 75mg/0.5ml solution for injection pre-filled syringes Xolair 150mg/1ml solution for injection pre-filled pens +1 Xolair 75mg/0.5ml solution for injection pre-filled syringes	not recorded	OMLYCLO Xolair	OMLYCLO® SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150 MG/1ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML	茁乐奥马珠单抗	not recorded	not recorded	not recorded	not recorded	not recorded	OMLYCLO 150 mg, solution injectable en seringue préremplie OMLYCLO 150 mg, solution injectable en stylo prérempli XOLAIR 150 mg, solution injectable en seringue préremplie +1 XOLAIR 150 mg, solution injectable en stylo prérempli
300 mg/2 mL injection	Manufacturer: Novartis Pharma Stein AG ×4 OMLYCLO Xolair	Omlyclo 75mg/0.5ml solution for injection pre-filled pens Omlyclo 75mg/0.5ml solution for injection pre-filled syringes Xolair 150mg/1ml solution for injection pre-filled pens +1 Xolair 75mg/0.5ml solution for injection pre-filled syringes	not recorded	Xolair	XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	XOLAIR 300 mg, solution injectable en seringue pré-remplie XOLAIR 300 mg, solution injectable en stylo pré-rempli
75 mg injection	not recorded	not recorded	not recorded	MOVABEY omalizumab (rch) 75 mg solution for injection pre-filled pen OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection pre-filled pen +3 XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe XOLAIR omalizumab (rch) 75mg powder for injection vial with diluent ampoule	not recorded	not recorded	OMLYCLO PRECARGADA Xolair	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg injection	not recorded	not recorded	not recorded	MOVABEY omalizumab (rch) 75 mg solution for injection pre-filled pen OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled pen OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled syringe with safety guard +2 XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe	not recorded	not recorded	OMLYCLO PRECARGADA	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg liquid	not recorded	not recorded	OMLYCLO Xolair	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL liquid	not recorded	not recorded	OMLYCLO Xolair	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
75 mg liquid	not recorded	not recorded	OMLYCLO Xolair	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1.2 mL injection	Manufacturer: Novartis Pharma Stein AG ×4 Xolair	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg powder	not recorded	not recorded	Xolair	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	OMLYCLO Xolair	not recorded	not recorded	not recorded	not recorded	not recorded	XOLAIR FOR INJ WITH SOLVENT 150MG XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML +2 XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML	OMLYCLO Xolair	not recorded
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	OMLYCLO	not recorded	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

5 more strength/form rows are recorded only in CA · MX and are not shown in this table. Hay 5 filas de concentración/forma registradas solo en CA · MX que no se muestran en esta tabla. 另有 5 个规格/剂型仅在 CA · MX 有记录（未在本表显示）。另有 5 個規格/劑型僅在 CA · MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

Omalizumab

AU 27 records · 7 strengths

GB 13 records · 4 strengths

CA 13 records · 4 strengths

US 11 records · 4 strengths

FR 10 records · 3 strengths

HK 8 records · 1 strengths

SG 7 records · 3 strengths

ES 7 records · 3 strengths

CN 5 records · 2 strengths

TW 3 records · 1 strengths

EU 2 records · 1 strengths

MX 1 records · 1 strengths